secwatch.observer — SEC 8-K summary
======================================

Issuer:     TransMedics Group, Inc. (TMDX)
CIK:        0001756262
Form:       8-K
Filed at:   2026-05-21T20:15:24+00:00
Accession:  0001193125-26-234440
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TransMedics shareholders approve director elections, equity plan amendment increasing share reserve to 5.39M shares
--------------------------------------------------------------------------------

- All eight director nominees elected; advisory say-on-pay approved with 22.9M for, 1.16M against.
- Amendment to 2019 Stock Incentive Plan approved: share reserve increased to 5,390,502 shares (includes 2,640,502 outstanding awards).
- Plan term extended to June 1, 2036; new grants on/after Jan 1, 2027 subject to minimum one-year vesting (5% carve-out).
- PricewaterhouseCoopers ratified as independent auditor for FY 2026 with 28.0M votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1756262/000119312526234440/0001193125-26-234440-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1756262/000119312526234440/d79022d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-234440

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer